SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-315984
Filing Date
2015-09-09
Accepted
2015-09-09 17:00:57
Documents
2
Period of Report
2015-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d85970d8k.htm 8-K 18197
2 SUBLICENSE AGREEMENT d85970dex101.htm EX-10.1 91029
  Complete submission text file 0001193125-15-315984.txt   110508
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 151099356
SIC: 8731 Services-Commercial Physical & Biological Research